Potential benefit of angiotensin converting enzyme inhibitors for hindering progression of Graves' ophthalmopathy.
Sagheb
Mohammad Mahdi
MM
Owji
Naser
N
Moini
Maryam
M
D000804:Angiotensin II / Q000378:metabolism; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D016207:Cytokines / Q000378:metabolism; D018450:Disease Progression; D049970:Graves Ophthalmopathy / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D006820:Hyaluronic Acid / Q000378:metabolism; D008954:Models, Biological; D008962:Models, Theoretical; D016212:Transforming Growth Factor beta / Q000378:metabolism; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D016207:Cytokines; D016212:Transforming Growth Factor beta; D000804:Angiotensin II; D006820:Hyaluronic Acid